Natural killer cell developmental pathways: A question of balance

Annual Review of Immunology

Volumn 24, Issue , 2006, Pages 257-286

  Di Santo, James P ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Commitment; Hematopoietic precursor; Lymphocyte; Transcription factor

Indexed keywords

ALPHA2 INTEGRIN; CD11B ANTIGEN; CD51 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR BETA; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LECTIN; LEUKOSIALIN; LYMPHOCYTE SURFACE MARKER; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR 1.1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN SH2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

BONE MARROW; CELL MATURATION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE HOMING; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THYMUS;

ANIMALS; ANTIGENS, SURFACE; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; MUTATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 33646180487     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.24.021605.090700     Document Type: Review

References (167)

1. Herberman RB, Nunn ME, Holden HT, Lavrin DH. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 16:230-39
2. Herberman RB, Nunn ME, Lavrin DH. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16:216-29
3. Kiessling R, Klein E, Pross H, Wigzell H. 1975. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur: J. Immunol. 5:117-21
4. Kiessling R, Klein E, Wigzell H. 1975. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5:112-17
5. Rosenberg EB, McCoy JL, Green SS, Donnelly FC, Siwarski DF, et al. 1974. Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J. Natl. Cancer Inst. 52:345-52
6. Herberman RB, Ortaldo JR. 1981. Natural killer cells: their roles in defenses against disease. Science 214:24-30
7. de Villartay JP, Fischer A, Durandy A. 2003. The mechanisms of immune diversification and their disorders. Nat. Rev. Immunol. 3:962-72
8. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-67
9. Trinchieri G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376
10. Yu YY, Kumar V, Bennett M. 1992. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10:189-213
11. Moffett-King A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2:656-63
12. Orange JS. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4:1545-58
13. French AR, Yokoyama WM. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15:45-51
14. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. 2005. Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nat. Immunol. 6:600-7
15. Pelayo R, Hirose J, Huang J, Garrett KP, Delogu A, et al. 2005. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105:4407-15
16. Colucci F, Schweighoffer E, Tomasello E, Turner M, Ortaldo JR, et al. 2002. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3:288-94
17. Puzanov IJ, Bennett M, Kumar V. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157:4282-85
18. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP. 2001. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31:1900-9
19. Kim S, Iizuka K, Kang HS, Dokun A, French AR, et al. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3:523-28
20. Colucci F, Di Santo JP, Leibson PJ. 2002. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat. Immunol. 3:807-13
21. Latour S, Veillette A. 2004. The SAP family of adaptors in immune regulation. Semin. Immunol. 16:409-19
22. Lanier LL. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-74
23. Moretta L, Moretta A. 2004. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23:255-59
24. Colucci F, Caligiuri MA, Di Santo JP. 2003. What does it take to make a natural killer? Nat. Rev. Immunol. 3:413-25
25. Takeda K, Cretney E, Hayakawa Y, Ota T, Akiba H, et al. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105:2082-89
26. 2 integrin, very late antigen-2). J. Immunol. 167:1141-44
27. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, et al. 2005. Activation of NK cell cytotoxicity. Mol. Immunol. 42:501-10
28. Screpanti V, Wallin RP, Ljuriggren HG, Grandien A. 2001. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167:2068-73
29. Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-40
30. Robertson MJ. 2002. Role of chemokinesin the biology of natural killer cells. J. Leukoc. Biol. 71:173-83
31. Maghazachi AA. 2003. G protein-coupled receptors in natural killer cells. J. Leukoc. Biol. 74:16-24
32. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052-57
33. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. 2002. A thymic precursor to the NK T cell lineage. Science 296:553-55
34. Loza MJ, Perussia B. 2001. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat. Immunol. 2:917-24
35. Karre K, Ljunggren HG, Piontek G, Kiessling R. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-78
36. Ljunggren HG, Karre K. 1990. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol. Today 11:237-44
37. Long EO. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:875-904
38. Yokoyama WM. 1993. Recognition structures on natural killer cells. Curr. Opin. Immunol. 5:67-73
39. Lanier LL. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-93
40. Raulet DH, Vance RE, McMahon CW. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:291-330
41. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105:4416-23
42. 41a. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709-13
43. 41b. Kumar V, McNerney ME. 2005. A new self:MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5:363-74
44. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, et al. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223
45. Raulet DH. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781-90
46. Yokoyama WM, Plougastel BF. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:304-16
47. Vivier E, Nunes JA, Vely F. 2004. Natural killer cell signaling pathways. Science 306:1517-19
48. Colucci F, Rosmaraki E, Bregenholt S, Samson SI, Di Bartolo V, et al. 2001. Functional dichotomy in natural killer cell signaling: Vav-1-dependent and -independent mechanisms. J. Exp. Med. 193:1-13
49. Cella M, Fujikawa K, Tassi I, Kim S, Latinis K, et al. 2004. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200:817-23
50. Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M. 2005. PLCγ2 is a critical signaling mediator for murine NK cell activating receptors. J. Immunol. 175:749-54
51. Upshaw JL, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ. 2005. The isoforms of phospholipase C-γ are differentially used by distinct human NK activating receptors. J. Immunol. 175:213-18
52. Carayannopoulos LN, Yokoyama WM. 2004. Recognition of infected cells by natural killer cells. Curr. Opin. Immunol. 16:26-33
53. Colonna M, Nakajima H, Navarro F, Lopez-Botet M. 1999. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66:375-81
54. Bendelac A, Bonneville M, Kearney JF. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1:177-86
55. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2:850-61
56. Du Pasquier L, Zucchetti I, De Santis R. 2004. Immunoglobulin superfamily receptors in protochordates: before RAG time. Immunol. Rev. 198:233-48
57. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-35
58. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, et al. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-37
59. Lee SH, Girard S, Macina D, Busa M, Zafer A, et al. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:42-45
60. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220
61. French AR, Pingel JT, Wagner M, Bubic I, Yang L, et al. 2004. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20:747-56
62. H1 priming. Nat. Immunol. 5:1260-55
63. Haller O, Kiessling R, Orn A, Wigzell H. 1977. Generation of natural killer cells: an autonomous function of the bone marrow. J. Exp. Med. 145:1411-16
64. Hackett J Jr, Bosma GC, Bosrna MJ, Bennett M, Kumar V. 1986. Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc. Natl. Acad. Sci. USA 483:3427-31
65. + hematopoietic progenitor cells. Blood 85:3538-46
66. +7+ NK progenitor. Blood 83:2594-601
67. + hematopoietic progenitor cells. Blood 87:2632-40
68. + cells into T cells. J. Immunol. 159:694-702
69. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:2375-80
70. Vosshenrich CA, Samson-Villeger SI, Di Santo JP. 2005. Distinguishing features of developing natural killer cells. Curr. Opin. Immunol. 17:151-58
71. Prlic M, Blazar BR, Farrar MA, Jameson SC. 2003. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197:967-76
72. Igarashi H, Gregory SC, Yokota T, Sakaguchi N, Kincade PW. 2002. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17:117-30
73. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-72
74. Terskikh AV, Miyamoto T, Chang C, Diatchenko L, Weissman IL. 2003. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102:94-101
75. Galy A, Travis M, Cen D, Chen B. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459-73
76. 73a. Blom B, Spits H. 2006. Development of human lymphoid cells. Annu. Rev. Immunol. 24:287-320
77. W/W mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity 17:277-88
78. W/W) mice. Adv. Exp. Med. Biol. 512:1-10
79. Michie AM, Carlyle JR, Schmitt TM, Ljutic B, Cho SK, et al. 2000. Clonal characterization of a bipotent T cell and NK cell progenitor in the mouse fetal thymus. J. Immunol. 164:1730-33
80. Douagi I, Colucci F, Di Santo JP, Cumano A. 2002. Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver. Blood 99:463-71
81. Carlyle JR, Michie AM, Cho SK, Zuniga-Pflucker JC. 1998. Natural killer cell development and function precede αβ T cell differentiation in mouse fetal thymic ontogeny. J. Immunol. 160:744-53
82. Spits H, Lanier LL, Phillips JH. 1995. Development of human T and natural killer cells. Blood 85:2654-70
83. Schmitt TM, Zuniga-Pflucker JC. 2002. Induction Of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749-56
84. Porritt HE, Rumfelt LL, Tabrizifard S, Schmitt TM, Zuniga-Pflucker JC, Petrie HT. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20:735-45
85. Schmitt TM, Ciofani M, Petrie HT, Zuniga-Pflucker JC. 2004. Maintenance of T cell specification and differentiation requires recurrent Notch receptor-ligand interactions. J. Exp. Med. 200:469-79
86. Taghon TN, David ES, Zuniga-Pflucker JC, Rothenberg EV. 2005. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19:965-78
87. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547-58
88. Ikawa T, Fujimoto S, Kawamoto H, Katsura Y, Yokota Y. 2001. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98:5164-69
89. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-80
90. Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, et al. 2005. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174:1213-21
91. bright natural killer cells. Immunity 22:295-304
92. + human natural killer cell progenitor that responds to interleukin-15. Blood 92:3647-57
93. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493-504
94. 7 integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J. Immunol. 167:2511-21
95. + multipotent marrow progenitor cells. J. Immunol. 163:2648-56
96. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1609-14
97. Melchers F, Haasner D, Streb M, Rolink A, 1992. B-lymphocyte lineage-committed, IL-7 and stroma cell-reactive progenitors and precursors, and their differentiation to B cells. Adv. Exp. Med. Biol. 323:111-17
98. Ware CF. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23:787-819
99. Iizuka K, Chaplin DD, Wang Y, Wu Q, Pegg LE, et al. 1999. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl. Acad. Sci. USA 96:6336-40
100. Lian RH, Chin RK, Nemeth LIE, Libby SL, Fu YX, Kumar V. 2004. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. Eur. J. Immunol. 34:2699-707
101. Stevenaert F, Van Beneden K, De Colvenaer V, Franki AS, Debacker V, et al. 2005. Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-β receptor expression. Blood 106:956-62
102. Wu Q, Sun Y, Wang J, Lin X, Wang Y, et al. 2001. Signal via lymphotoxin-βR on bone marrow stromal cells is required for an early checkpoint of NK cell development. J. Immunol. 166:1684-89
103. Sivakumar V, Hammond KJ, Howells N, Pfeffer K, Weih F. 2003. Differential requirement for Rel/nuclear factor κB family members in natural killer T cell development. J. Exp. Med. 197:1613-21
104. Chen KS, DeLuca HF. 1994. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta 1219:26-32
105. Lee KN, Kang HS, Jeon JH, Kim EM, Yoon SR, et al. 2005. VDUP1 is required for the development of natural killer cells. Immunity 22:195-208
106. Rothenberg EV, Taghon T. 2005. Molecular genetics of T cell development. Annu. Rev. Immunol. 23:601-49
107. Singh H, Medina KL, Pongubala JM. 2005. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102:4949-53
108. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-77
109. DeKoter RP, Lee HJ, Singh H. 2002. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16:297-309
110. Medina KL, Pongubala JM, Reddy KL, Lancki DW, Dekoter R, et al. 2004. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7:607-17
111. Maeurer MJ, Lotze MT. 1998. Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int. Rev. Immunol. 16:309-22
112. Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, et al. 2003. GATA-3 promotes maturation, IFN-γ production, and liver-specific homing of NK cells. Immunity 19:701-11
113. Colucci F, Samson SI, DeKoter RP, Lantz O, Singh H, Di Santo JP. 2001. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97:2625-32
114. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L. 2005. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201:221-31
115. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, et al. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:555-63
116. Boggs SS, Trevisan M, Patrene K, Geogopoulos K. 1998. Lack of natural killer cell precursors in fetal liver of Ikaros knockout mutant mice. Nat. Immunol. 16:137-45
117. Engel I, Murre C. 2001. The function of E- and Id proteins in lymphocyte development. Nat. Rev. Immunol. 1:193-99
118. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, et al. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-92
119. Heemskerk MH, Blom B, Nolan G, Stegmann AP, Bakker AQ, et al. 1997. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186:1597-602
120. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397:702-6
121. Ikawa T, Kawamoto H, Fujimoto S, Katsura Y. 1999. Commitment of common T/natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J. Exp. Med. 190:1617-26
122. Massari ME, Grant PA, Pray-Grant MG, Berger SL, Workman JL, Murre C. 1999. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4:63-73
123. Ikawa T, Kawamoto H, Wright LY, Murre C. 2004. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20:349-60
124. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV. 1999. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126:3131-48
125. +Lin- bone marrow cells. J. Immunol. 171:683-90
126. DeHart SL, Heikens MJ, Tsai S. 2005. Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines. Blood 105:3521-27
127. Cooper MA, Bush JE, Fehniger TA, VanDeusen JB, Waite RE, et al. 2002. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100:3633-38
128. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-80
129. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Muller W, Di Santo JP. 2003. IL-15 is an essential mediator of peripheral NK cell homeostasis. Blood 101:4887-93
130. Dubois S, Mariner J, Waldmann TA, Tagaya Y. 2002. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17:537-47
131. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, et al. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700-3.
132. Erratum. 1998. Nature 392(6678):843
133. Taki S, Nakajima S, Ichikawa E, Saito T, Hida S. 2005. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J. Immunol. 174:6005-12
134. Kawamura T, Koka R, Ma A, Kumar V. 2003. Differential roles for IL-15R α-chain in NK cell development and Ly-49 induction. J. Immunol. 171:5085-90
135. Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. 2004. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172:864-70
136. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, et al. 1997. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99:937-43
137. Iizuka K, Chaplin DD, Wang Y, Wu Q, Pegg LE, et al. 1999. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl. Acad. Sci. USA 96:6336-40
138. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, et al. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:1455-62
139. Bloch-Queyrat C, Fondaneche MC, Chen R, Yin L, Relouzat F, et al. 2005. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202:181-92
140. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3:1150-55
141. Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, et al. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18:41-51
142. Wu J, Song Y, Bakker AB, Bauer S, Spies T, et al. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285:730-32
143. Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, et al. 2005. Requirement of homotypic NK cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood. In press
144. Wilde JI, Watson SP. 2001. Regulation of phospholipase Cγ isoforms in haematopoietic cells: why one, not the other? Cell. Signal. 13:691-701
145. Wang D, Feng J, Wen R, Marine JC, Sangster MY, et al. 2000. Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors. Immunity 13:25-35
146. 141a. Caraux A, Kim N, Bell SE, Zompi S, Ranson T, et al. 2005. Phospholipase C-γ2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood. In press
147. Ting AT, Karnitz LM, Schoon RA, Abraham RT, Leibson PJ. 1992. Fey receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γ 1 and PLC-γ 2 in natural killer cells. J. Exp. Med. 176:1751-55
148. Caraux A, Lu Q, Fernandez N, Di Santo JP, Raulet DH, Lemke G, et al. 2004. Receptor Tyrosine kinases of the Tyro 3 family play a critical role in natural killer cell differentiation. Presented at 8th Meet. Soc. Nat. Immun., The Netherlands
149. Crosier KE, Crosier PS. 1997. New insights into the control of cell growth; the role of the AxI family. Pathology 29:131-35
150. Townsend MJ, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, et al. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20:477-94
151. Lohoff M, Duncan GS, Ferrick D, Mittrucker HW, Bischof S, et al. 2000. Deficiency in the transcription factor Interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 192:325-36
152. + T cell homeostasis. J. Exp. Med. 200:825-34
153. Koka R, Burkett PR, Chien M, Chai S, Chan F, et al. 2003. Interleukin (IL)-15Rα-deficient natural killer cells survive in normal but not IL-15Rα-deficient mice. J. Exp. Med. 197:977-84
154. Schluns KS, Nowak EC, Cabrera-Hernandez A, Puddington L, Lefrancois L, Aguila HL. 2004. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor α expression. Proc. Natl. Acad. Sci. USA 101:5616-21
155. Brady J, Hayakawa Y, Smyth MJ, Nutt SL. 2004. IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172:2048-58
156. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, et al. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100:2663-68
157. Schmidt-Weber CB, Blaser K. 2004. Regulation and role of transforming growth factor-β in immune tolerance induction and inflammation. Curr. Opin. Immunol. 16:709-16
158. Kulkarni AB, Huh CG, BeckerD, Geiser A, Lyght M, et al. 1993. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770-74
159. Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, et al. 2003. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100:4120-25
160. von Boehmer H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6:338-44
161. Haller O, Wigzell H. 1977. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J. Immunol. 118:1503-6
162. Seaman WE, Gindhart TD, Greenspan JS, Blackman MA, Talal N. 1979. Natural killer cells, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice. J. Immunol. 122:2541-47
163. Manz RA, Thiel A, Radbruch A. 1997. Lifetime of plasma cells in the bone marrow. Nature 388:133-34
164. + T cells. Immunity 22:259-70
165. Garni-Wagner BA, Witte PL, Tutt MM, Kuziel WA, Tucker PW, et al. 1990. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency. J. Immunol. 144:796-803
166. Hansson M, Karre K, Kiessling R, Roder J, Andersson B, Hayry P. 1979. Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population. J. Immunol. 123:765-71
167. Moffet-King A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2:656-63